13F filer · CIK 1037792 ↗
Paradigm Capital Management Inc
You are looking at Q2 2024. See the latest, Q2 2026 →
Reported value
$2.19B
+5.1% on the quarter before
Positions
129
5 new · 7 sold out
Top 10
52.6%
of the value
Est. gain
+$94.0M
on stocks held all quarter
Est. return
+4.7%
on those stocks since Q1 2024
Positions as of Jun 30, 2024, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.
Largest buys
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Concentrix Corp~$22.0MAdded · 0.9% → 1.8%+348,100 shares
- Adtran Inc~$8.2MAdded · 0.2% → 0.6%+1,551,000 shares
- Orthofix Medical Inc.~$8.1MAdded · 1.4% → 1.5%+609,137 shares
- Tactile Systems Technology~$6.7MAdded · 0.5% → 0.6%+561,073 shares
- J Jill Group~$6.3MAdded · 0.3% → 0.6%+181,116 shares
- American Woodmark Corporation~$6.2MNew · 0.0% → 0.3%+79,000 shares
- Calix Inc~$4.1MAdded · 1.9% → 2.2%+115,500 shares
- Tela Bio, Inc.~$3.5MAdded · 0.1% → 0.3%+740,935 shares
- Si-Bone, Inc.~$3.5MAdded · 0.8% → 0.8%+267,100 shares
- Trubridge, Inc.~$3.1MAdded · 0.0% → 0.1%+305,089 shares
Largest sells
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ducommun Inc~$18.2MCut · 3.4% → 2.9%−312,700 shares
- Semtech~$16.8MCut · 0.8% → 0.0%−562,200 shares
- Ciena~$11.8MSold out · 0.6% → 0.0%−239,000 shares
- Onto Innovation~$8.8MCut · 10.0% → 11.1%−40,000 shares
- Citi Trends, Inc.~$4.0MCut · 0.8% → 0.4%−186,870 shares
- Angiodynamics, Inc.~$3.6MCut · 0.3% → 0.1%−601,079 shares
- Coherent Inc~$3.0MSold out · 0.1% → 0.0%−50,000 shares
- Veradigm Inc.~$2.9MSold out · 0.1% → 0.0%−370,600 shares
- Pennant Group Inc.~$2.6MCut · 1.1% → 1.2%−110,400 shares
- Modine~$2.1MCut · 7.6% → 7.5%−20,600 shares
Holdings
As of Jun 30, 2024. Changes are in shares against Mar 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Onto InnovationCOM · shares −3.5% · price +21.3% | 11.1% | $243.8M | +$42.7M | ||||||||
| ModineCOM · shares −1.2% · price +5.3% | 7.5% | $165.2M | +$8.2M | ||||||||
| FabrinetCOM · shares −0.4% · price +29.5% | 6.0% | $131.7M | +$30.0M | ||||||||
| BroadcomCOM · shares 0% · price +21.1% | 5.9% | $129.9M | +$22.7M | ||||||||
| Insight EnterprisesCOM · shares −0.5% · price +6.9% | 5.4% | $118.3M | +$7.7M | ||||||||
| Veeco InstrumentsCOM · shares −2.2% · price +32.8% | 4.1% | $90.3M | +$22.3M | ||||||||
| EntegrisCOM · shares 0% · price −3.7% | 3.3% | $72.3M | −$2.7M | ||||||||
| Extreme NetworksCOM · shares 0% · price +16.6% | 3.3% | $71.6M | +$10.2M | ||||||||
| Globus MedicalCOM · shares −1.0% · price +27.7% | 3.1% | $68.6M | +$14.9M | ||||||||
| JabilCOM · shares +1.0% · price −18.8% | 2.9% | $63.3M | −$14.5M | ||||||||
| Ducommun IncCOM · shares −22% · price +13.2% | 2.9% | $63.1M | +$7.3M | ||||||||
| R1 Rcm, Inc NewCOM · shares 0% · price −2.5% | 2.5% | $55.9M | −$1.4M | ||||||||
| Axcelis TechnologiesCOM · shares +5.9% · price +27.5% | 2.3% | $49.7M | +$10.1M | ||||||||
| Calix IncCOM · shares +9.5% · price +6.8% | 2.2% | $47.4M | +$2.8M | ||||||||
| Ensign Group, Inc.COM · shares −0.03% · price −0.6% | 2.0% | $43.3M | −$255,573 | ||||||||
| EnersysCOM · shares 0% · price +9.6% | 1.9% | $42.7M | +$3.7M | ||||||||
| Concentrix CorpCOM · shares +126% · price −4.4% | 1.8% | $39.5M | −$809,799 | ||||||||
| Ribbon Communications IncCOM · shares +4.1% · price +2.8% | 1.6% | $34.7M | +$911,376 | ||||||||
| Orthofix Medical Inc.COM · shares +31% · price −8.7% | 1.5% | $33.9M | −$2.5M | ||||||||
| Enviri CorpCOM · shares +3.5% · price −5.7% | 1.5% | $33.7M | −$2.0M | ||||||||
| Ultra Clean Holdings IncCOM · shares 0% · price +6.7% | 1.5% | $32.3M | +$2.0M | ||||||||
| Summit Materials, Inc. Class ACOM · shares 0% · price −17.9% | 1.4% | $31.1M | −$6.8M | ||||||||
| Infinera CorpCOM · shares −0.6% · price +1.0% | 1.4% | $30.4M | +$299,928 | ||||||||
| MimedxCOM · shares +6.6% · price −10.0% | 1.3% | $28.9M | −$3.0M | ||||||||
| Aviat Networks Inc Com NewCOM · shares −0.3% · price −25.2% | 1.3% | $28.7M | −$9.6M | ||||||||
| Total · 129 positions | 100% | $2.19B | +$94.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2024 to Q2 2024: 124 stocks held throughout, up $94.0M (+4.7%).
- Onto Innovation+$42.7M+21%
- Fabrinet+$30.0M+30%
- Broadcom+$22.7M+21%
- Veeco Instruments+$22.3M+33%
- Globus Medical+$14.9M+28%
- Builders Firstsource Inc−$6.0M−34%
- Summit Materials, Inc. Class A−$6.8M−18%
- Aviat Networks Inc Com New−$9.6M−25%
- Jabil−$14.5M−19%
- Cerence−$22.4M−82%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $3.67B+41% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $2.61B+10% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $2.38B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.31B+12% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.05B+14% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.80B−17% | SEC ↗ |
| Q4 2024 | Feb 18, 2025 | $2.16B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.25B+3% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.19B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.09B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.92B+10% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.74B−0% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.75B+16% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $1.51B−0% | SEC ↗ |
| Q4 2022 | Feb 3, 2023 | $1.51B+9% | SEC ↗ |
| Q3 2022 | Oct 26, 2022 | $1.39B−6% | SEC ↗ |
| Q2 2022 | Aug 2, 2022 | $1.47B−20% | SEC ↗ |
| Q1 2022 | May 25, 2022 | $1.85B−17% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $2.24B+15% | SEC ↗ |
| Q3 2021 | Nov 8, 2021 | $1.94B−7% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $2.08B+8% | SEC ↗ |
| Q1 2021 | May 5, 2021 | $1.93B+15% | SEC ↗ |
| Q4 2020 | Jan 20, 2021 | $1.67B+41% | SEC ↗ |
| Q3 2020 | Oct 20, 2020 | $1.19B+9% | SEC ↗ |
| Q2 2020 | Aug 3, 2020 | $1.09B+32% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $827.9M−36% | SEC ↗ |
| Q4 2019 | Feb 5, 2020 | $1.30B+16% | SEC ↗ |
| Q3 2019 | Nov 7, 2019 | $1.12B+2% | SEC ↗ |
| Q2 2019 | Aug 8, 2019 | $1.10B−4% | SEC ↗ |
| Q1 2019 | May 10, 2019 | $1.14B+12% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.02B−20% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $1.27B+3% | SEC ↗ |
| Q2 2018 | Aug 8, 2018 | $1.24B+5% | SEC ↗ |
| Q1 2018 | Apr 9, 2018 | $1.18B+1% | SEC ↗ |
| Q4 2017 | Feb 7, 2018 | $1.17B+2% | SEC ↗ |
| Q3 2017 | Nov 6, 2017 | $1.15B+4% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.11B+5% | SEC ↗ |
| Q1 2017 | May 9, 2017 | $1.06B+3% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $1.03B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $953.0M+16% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $820.6M−4% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $858.8M | SEC ↗ |